Drug interactions between Crixivan and Levitra
Results for the following 2 drugs: |
|
|---|---|
| Crixivan (indinavir) | |
| Levitra (vardenafil) | |
Interactions between your selected drugs
indinavir ⇔ vardenafil
Applies to: Crixivan (indinavir) and Levitra (vardenafil)
ADJUST DOSE: Coadministration with indinavir may significantly increase the plasma concentrations of vardenafil. The mechanism is indinavir inhibition of CYP450 3A4, the isoenzyme primarily responsible for the metabolic clearance of vardenafil. According to vardenafil labeling, coadministration of indinavir (800 mg three times a day) and vardenafil (10 mg) resulted in a 7-fold increase in the peak plasma concentration (Cmax), a 16-fold increase in the area under the concentration-time curve (AUC), and a 2-fold increase in the half-life of vardenafil. Indinavir Cmax and AUC were reduced by 40% and 30%, respectively.
MANAGEMENT: Patients treated with indinavir should not receive more than a single 2.5 mg dose of vardenafil within a 24-hour period. Patients should be advised to promptly notify their physician if they experience pain or tightness in the chest or jaw, irregular heartbeat, nausea, shortness of breath, visual disturbances, syncope, or prolonged erection (greater than 4 hours).
See also...
Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. Multum's drug information does not endorse drugs, diagnose patients, or recommend therapy. Multum's drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2009 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
